Strandberg, Timo E <br/><br/>
Secondary prevention of stroke is important: but all hypertensive drugs are not created equal?  [electronic resource] 

 -  Stroke  Jun 2005 
 - 1225-6 p.  digital 
<br/><br/> Publication Type: Comment; Editorial 
<br/><br/><label>ISSN: </label>1524-4628 
<br/><br/><label>Standard No.: </label>10.1161/01.STR.0000166044.06026.46  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin II Type 1 Receptor Blockers--therapeutic use<br/>Animals<br/>Antihypertensive Agents--therapeutic use<br/>Brain Ischemia--drug therapy<br/>Clinical Trials as Topic<br/>Humans<br/>Hypertension--drug therapy<br/>Ischemic Attack, Transient--pathology<br/>Myocardial Infarction--etiology<br/>Research Design<br/>Risk<br/>Stroke--pathology